Global Blood Testing Market- Growth, Trends and Forecasts 2017 - 2022

  • ID: 4388403
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 4
The blood testing market for the year 2013 is about $xx billion and reached $xx billion in 2014. With its latest advancements and new technological approaches, the blood testing market is expected to grow $xx billion by 2020, with a compound annual growth rate (CAGR) of xx%.

Blood testing is a laboratory analysis performed on blood sample taken from patient's body with the help of needle or finger prick to determine the state of health. The function of organs and how well a treatment is working can be determined by blood culture tests. These tests are very common and even the regular checkup might require one, because of which the market for blood culture test is growing.

The blood test market that performs automated testing is expected to grow more at a high rate as demand for advanced approaches is more. The most common types of blood tests include a complete blood count, blood chemistry tests, blood enzyme tests and blood tests to assess heart diseases.

This report also focuses on cost effective, simplified and high-on-demand blood collection tools driving the market growth.

The key market players in the blood culture test market include bioMerieux SA (France), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens AG (Germany), Bruker Corporation (U.S.), Cepheid (U.S.), Alere, Inc. (U.S.), Abbott Laboratories (U.S.), and Nanosphere, Inc. (U.S.)

Market Drivers

The increase in the incidence of diseases such as blood stream infections, kidney disorders and other organ infections, aging population, high demand for rapid diagnostic tests are certain factors that drive the market.

Market Restraints

The cost of highly automated blood testing, regulatory approval processes and lack of awareness on latest advancements however hinder the market growth.

Key Deliverables in the Study?

1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2) Market analysis for the Global Blood Testing Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.

3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

5)Identification and analysis of the Macro and Micro factors that affect the Global Blood Testing Market in Healthcare Industry on both global and regional scale.

6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
2 BLOOD TESTING MARKET OVERVIEW
3 GLOBAL BLOOD TESTING – MARKET FORCES
3.1 MARKET DRIVERS
3.1.1 Increased incidence of diseases
3.1.2 Aging population
3.1.3 Demand for rapid diagnostic tests
3.2 MARKET RESTRAINTS
3.2.1 High cost of advanced technologies
3.2.2 Regulatory approval process
3.2.3 Lack of awareness on advancements
4. PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5 GLOBAL BLOOD TESTING MARKET, BY TYPES
5.1 OVERVIEW
5.2 COMPLETE BLOOD COUNT
5.2.0 Red blood cells
5.2.1 White blood cells
5.2.2 Hemoglobin
5.2.3 Hematocrit
5.2.4 Platelets
5.3 BLOOD CHEMISTRY TESTS/ BASIC METABOLIC PANEL
5.3.0 Test for Electrolytes
5.3.1 Blood Glucose
5.3.2 Calcium
5.3.3 Test for Kidney Function
5.4 BLOOD ENZYME TESTS
5.4.0 Troponin
5.4.1 Creatine kinase
5.5 CARDIAC BLOOD TESTS
5.5.0 C-­Reactive Protein
5.5.1 Total Cholesterol
5.6 BLOOD CLOTTING TESTS
5.6.0 Prothrombin time and Activated Partial Thromboplastin time
5.6.1 Blood Coagulation
6 GLOBAL BLOOD TESTING MARKET, BY DISEASES
6.1 Anemia
6.2 Infection
6.3 Leukemia
6.4 Hypokalemia
6.5 Kidney Disorders
6.6 Heart Attack
6.7 Coronary Heart Disease
6.8 Other Diseases
7 GLOBAL BLOOD TESTING MARKET, BY METHODS
7.1 Manual blood culture testing
7.2 Automated blood culture testing
7.2.0 Automated Blood culture system
7.2.0.1 Blood culture instruments
7.2.1 Advancements in blood collection tools
8 BLOOD TESTING MARKET, BY GEOGRAPHY
8.1 Overview
8.1.1 North America
8.1.2 Europe
8.1.3 Asia-­Pacific
8.1.4 Rest of the World
9 COMPETITIVE LANDSCAPE
10 COMPANY PROFILES
10.1.0 Theranos
10.1.1 Genteel
10.1.2 Tasso
10.1.3 Abbott Laboratories
10.1.4 Ortho Clinical Diagnostics
10.1.5 Bio­Rad Laboratories
10.1.6 Baxter International
10.1.7 Gen­Probe, Inc.
10.1.8 Novartis Diagnostics
10.1.9 Roche Diagnostics
10.1.10 Becton Dickinson & Company
10.1.11 Biomerica, Inc.
10.1.12 BioMerieux, Inc.
10.1.13 Cepheid Corporation
10.1.14 Meridian Bioscience,Inc
11. Appendix
11.1 Abbrevations
11.2 Bibliography
11.3 Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll